Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research for Patient Benefit programme-London Competition 47 stage 1 competition 46 stage 2 Minutes

Contents

Published: 26 July 2022

Version: 1.0 July 2022

Print this document

Minutes for the Research for Patient Benefit (RfPB) programme London Regional Advisory Committee meeting to discuss Stage 2 applications to competition 46 and Stage 1 applications to competition 47.

Date and Location

Thursday 19 May 2022 Virtual Meeting

In attendance

Committee members

Dr Chris Gale (Chair)
Dr Jacqueline Birks
Dr Thomas Booth
Miss Eva Broeckelmann
Dr Julia Chisholm
Professor Francesco D'Aiuto
Ms Mikaela Davies
Dr Anna De Simoni
Dr Martina Di Simplicio
Dr Johnny Downs
Dr Philip Kinghorn
Dr Rachel Philips
Dr Katie Sheehan
Dr Charlotte Warren-Gash

Secretariat

Mr Richard Foulsham (NIHR CCF)
Dr Laura Tornatore (NIHR CCF)
Ms Zaynab Manea (NIHR CCF)
Ms Lavpreet Ranjit (NIHR CCF)
Professor Marian Knight (Programme Director)

Apologies

 Apologies were received from Dr Elizabeth Bancroft, Mr Martin Carroll, and Professor Christina Victor

Competition 46 stage 2 applications considered

NIHR204123: Systematic review & network meta-analysis of randomised controlled trials comparing antithrombotic drugs for cardiovascular risk reduction in patients with lower limb peripheral arterial disease
Conflicts: None
Final outcome: Support

NIHR204088: Mobile telephone contingency management to encourage adherence to supervised medication among individuals receiving opioid agonist treatment: a feasibility study (TIES2)
Conflicts: Professor Francesco D'Aiuto, Dr Johnny Downs, Dr Thomas Booth
Final outcome: Support

NIHR204011: OsteoPorosis Tailored digital Intervention for Improving SElf-management (OPTImISE study)
Conflicts: None
Final outcome: Reject

NIHR204120: The development and evaluation of a crisis-focused psychosocial intervention for people who have experience of complex emotional needs: A feasibility Randomised Controlled Trial (RCT)
Conflicts: Professor Francesco D'Aiuto, Dr Johnny Downs, Miss Eva Broeckelmann, Dr Rachel Philips
Final outcome: Reject

NIHR204109: A randomised feasibility study of standard face-to face group X-PERT patient education versus digital and virtual X-PERT patient education for patients with Type 2 Diabetes
Conflicts: None
Final outcome: Reject

Competition 47 stage 1 applications considered

NIHR204378: Improving Memory in Schizophrenia with TDCS brain stimulation
Conflicts: None
Outcome: Reject

NIHR204347: A randomised trial assessing the duration of anti-coagulation treatment for LV thrombus of ischaemic aetiology (DURATION-LVT Study)
Conflicts: Professor Francesco D'Aiuto
Outcome: Invite to Stage 2

NIHR204388: Exploring the risk and protective factors for suicide following a dementia diagnosis
Conflicts: Professor Christina Victor
Outcome: Reject

NIHR204385: Protecting hospitalised children from nosocomial respiratory viral infections: lessons learnt from SARS-CoV-2
Conflicts: None
Outcome: Reject

NIHR204383: An Ethical Framework for Decision making in Long-term Ventilation in Children and Young People– the Feasibility of a Stepped Wedge Cluster RCT National Evaluation
Conflicts: Dr Rachel Phillips
Outcome: Reject

NIHR204381: Postnatal Optimisation Study (POST)
Conflicts: None
Outcome: Reject

NIHR204342: Understanding the costs, health consequences and barriers to using RNA sequencing-based selection of rituximab for people with rheumatoid arthritis (R4-RA-Econ)
Conflicts: Professor Francesco D'Aiuto
Outcome: Invite to Stage 2

NIHR204370: Evaluation of a novel multi-component anxiety management programme for the treatment of anxiety disorder in people with Intellectual disability
Conflicts: None
Outcome: Invite to Stage 2

Outcomes tables

The tables below display the mean score for each application that was assessed in the regional assessment committee meeting, and excludes applications which were rejected during the scrutiny and triage processes. The number of applications receiving each mean score are listed. The RfPB fundable range is 6-10, although a score of 6-10 does not guarantee funding or an invitation to Stage 2. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.

In exceptional circumstances, applications which fall below the fundable range may be invited to Stage 2 or recommended for funding by the Committee. The Programme Director reviews in detail any applications recommended for funding with a score below 7.

Stage 1

ScoreRangeNumber of applications
9.0 - 10.0 Invited 0
8.0 -.8.9 Invited 1
7.0 - 7.9 Invited 1
6.0 - 6.9 Invited 1
5.0 - 5.9 Rejected 1
4.0 - 4.9 Rejected 3
3.0 - 3.9 Rejected 1
2.0 - 2.9 Rejected 0
1.0 - 1.9 Rejected 0

Stage 2 

ScoreRangeNumber of applications
9.0 - 10.0 Fundable 0
8.0 - 8.9 Fundable 1
7.0 - 7.9 Fundable 1
6.0 - 6.9 Fundable/Rejected 0
5.0 - 5.9 Rejected 0
4.0 - 4.9 Rejected 1
3.0 - 3.9 Rejected 2
2.0 - 2.9 Rejected 0
1.0 - 1.9 Rejected 0